Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial: correction
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
April 2024
|
| In: |
Leukemia
Year: 2024, Jahrgang: 38, Heft: 4, Pages: 925-925 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-024-02184-z |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-024-02184-z Verlag, kostenfrei, Volltext: http://www.nature.com/articles/s41375-024-02184-z 
|
| Verfasserangaben: | Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Satu Mustjoki, Andreja Dimitrijevic, Jesper Stentoft, Waleed Majeed, Lydia Roy, Dominik Wolf, Arta Dreimane, Bjørn Tore Gjertsen, Tobias Gedde-Dahl, Erik Ahlstrand, Berit Markevärn, Henrik Hjorth-Hansen, Jeroen Janssen and Ulla Olsson-Strömberg |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1908288280 | ||
| 003 | DE-627 | ||
| 005 | 20241205220058.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241112s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-024-02184-z |2 doi | |
| 035 | |a (DE-627)1908288280 | ||
| 035 | |a (DE-599)KXP1908288280 | ||
| 035 | |a (OCoLC)1475647327 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Flygt, Hjalmar |e VerfasserIn |0 (DE-588)1348028327 |0 (DE-627)1908287527 |4 aut | |
| 245 | 1 | 0 | |a Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial |b correction |c Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Satu Mustjoki, Andreja Dimitrijevic, Jesper Stentoft, Waleed Majeed, Lydia Roy, Dominik Wolf, Arta Dreimane, Bjørn Tore Gjertsen, Tobias Gedde-Dahl, Erik Ahlstrand, Berit Markevärn, Henrik Hjorth-Hansen, Jeroen Janssen and Ulla Olsson-Strömberg |
| 264 | 1 | |c April 2024 | |
| 300 | |a 1 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 28. Februar 2024 | ||
| 500 | |a Gesehen am 12.11.2024 | ||
| 650 | 4 | |a Myeloproliferative disease | |
| 650 | 4 | |a Targeted therapies | |
| 700 | 1 | |a Söderlund, Stina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Richter, Johan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Saußele, Susanne |d 1968- |e VerfasserIn |0 (DE-588)115839860 |0 (DE-627)69162786X |0 (DE-576)29010694X |4 aut | |
| 700 | 1 | |a Koskenvesa, Perttu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stenke, Leif |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mustjoki, Satu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dimitrijevic, Andreja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stentoft, Jesper |e VerfasserIn |4 aut | |
| 700 | 1 | |a Majeed, Waleed |e VerfasserIn |4 aut | |
| 700 | 1 | |a Roy, Lydia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wolf, Dominik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dreimane, Arta |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gjertsen, Bjørn Tore |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gedde-Dahl, Tobias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ahlstrand, Erik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Markevärn, Berit |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hjorth-Hansen, Henrik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Janssen, Jeroen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Olsson-Strömberg, Ulla |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 38(2024), 4 vom: Apr., Seite 925-925 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial correction |
| 773 | 1 | 8 | |g volume:38 |g year:2024 |g number:4 |g month:04 |g pages:925-925 |g extent:1 |a Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial correction |
| 787 | 0 | 8 | |i Errata zu |a Flygt, Hjalmar |t Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial |d 2024 |w (DE-627)190828711X |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41375-024-02184-z |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://www.nature.com/articles/s41375-024-02184-z |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241112 | ||
| 993 | |a Editorial | ||
| 994 | |a 2024 | ||
| 998 | |g 115839860 |a Saußele, Susanne |m 115839860:Saußele, Susanne |d 60000 |d 61200 |d 60000 |e 60000PS115839860 |e 61200PS115839860 |e 60000PS115839860 |k 0/60000/ |k 1/60000/61200/ |k 0/60000/ |p 4 | ||
| 999 | |a KXP-PPN1908288280 |e 4613333008 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"note":["Online veröffentlicht: 28. Februar 2024","Gesehen am 12.11.2024"],"name":{"displayForm":["Hjalmar Flygt, Stina Söderlund, Johan Richter, Susanne Saussele, Perttu Koskenvesa, Leif Stenke, Satu Mustjoki, Andreja Dimitrijevic, Jesper Stentoft, Waleed Majeed, Lydia Roy, Dominik Wolf, Arta Dreimane, Bjørn Tore Gjertsen, Tobias Gedde-Dahl, Erik Ahlstrand, Berit Markevärn, Henrik Hjorth-Hansen, Jeroen Janssen and Ulla Olsson-Strömberg"]},"physDesc":[{"extent":"1 S."}],"title":[{"subtitle":"correction","title_sort":"Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial","title":"Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.1038/s41375-024-02184-z"],"eki":["1908288280"]},"origin":[{"dateIssuedDisp":"April 2024","dateIssuedKey":"2024"}],"person":[{"given":"Hjalmar","display":"Flygt, Hjalmar","role":"aut","family":"Flygt"},{"given":"Stina","display":"Söderlund, Stina","role":"aut","family":"Söderlund"},{"family":"Richter","role":"aut","display":"Richter, Johan","given":"Johan"},{"given":"Susanne","display":"Saußele, Susanne","family":"Saußele","role":"aut"},{"display":"Koskenvesa, Perttu","given":"Perttu","role":"aut","family":"Koskenvesa"},{"given":"Leif","display":"Stenke, Leif","family":"Stenke","role":"aut"},{"display":"Mustjoki, Satu","given":"Satu","family":"Mustjoki","role":"aut"},{"display":"Dimitrijevic, Andreja","given":"Andreja","role":"aut","family":"Dimitrijevic"},{"family":"Stentoft","role":"aut","display":"Stentoft, Jesper","given":"Jesper"},{"family":"Majeed","role":"aut","given":"Waleed","display":"Majeed, Waleed"},{"family":"Roy","role":"aut","given":"Lydia","display":"Roy, Lydia"},{"family":"Wolf","role":"aut","display":"Wolf, Dominik","given":"Dominik"},{"display":"Dreimane, Arta","given":"Arta","family":"Dreimane","role":"aut"},{"display":"Gjertsen, Bjørn Tore","given":"Bjørn Tore","role":"aut","family":"Gjertsen"},{"role":"aut","family":"Gedde-Dahl","given":"Tobias","display":"Gedde-Dahl, Tobias"},{"given":"Erik","display":"Ahlstrand, Erik","family":"Ahlstrand","role":"aut"},{"role":"aut","family":"Markevärn","display":"Markevärn, Berit","given":"Berit"},{"role":"aut","family":"Hjorth-Hansen","given":"Henrik","display":"Hjorth-Hansen, Henrik"},{"family":"Janssen","role":"aut","given":"Jeroen","display":"Janssen, Jeroen"},{"role":"aut","family":"Olsson-Strömberg","display":"Olsson-Strömberg, Ulla","given":"Ulla"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial correctionLeukemia","id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"title":[{"title":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title_sort":"Leukemia"}],"pubHistory":["Nachgewiesen 11.1997 -"],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"note":["Gesehen am 15.03.04"],"recId":"32046699X","part":{"text":"38(2024), 4 vom: Apr., Seite 925-925","issue":"4","year":"2024","extent":"1","pages":"925-925","volume":"38"},"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group"}]}],"recId":"1908288280"} | ||
| SRT | |a FLYGTHJALMCORRECTION2024 | ||